Latest Clinical & Research News
Specialty: Otolaryngology
Using prospectively collected registry data, researchers at Brigham and Women’s Hospital linked increased severity of sinonasal symptoms in patients with aspirin-exacerbated respiratory disease to both worse patient-reported asthma control and worse objectively measured lung function.
Read More...
The COVID-19 pandemic has dealt a blow to faculty membership and sponsorship programs at many healthcare institutions. In response, the Brigham is piloting a new Faculty Mentorship and Sponsorship Network Program. Laryngologist and associate surgeon Anju K. Patel, MD, who spearheads the program, discusses its impact.
Read More...
A 77-year-old woman, whose past medical history included type 2 diabetes, end-stage renal disease and hypertension, presented to the emergency department with a two-month history of severe left ear and facial pain. Imaging demonstrated changes in soft tissue and bone that were concerning for skull base osteomyelitis.
Read More...
Researchers at Brigham and Women’s Hospital sought to answer whether the association between SNOT-22 and CT results could be improved by rating partial opacification more precisely. Instead, they found the relationship between the two assessment methods is affected by incidental causes of opacification.
Read More...
Emily Moldoff, NP, Carleton Eduardo Corrales, MD, and Jennifer J. Shin, MD, and colleagues have documented that the noise generated by powered air-purifying respirators creates a substantial barrier to communication during clinical interactions.
Read More...
Laryngopharyngeal reflux disease (LPR), an inflammatory condition related to the direct and indirect effects of gastroduodenal content reflux, affects up to 30 percent of otolaryngology patients worldwide. The condition leads to symptoms including chronic throat clearing and cough, excess throat mucus, postnasal drip and vocal changes, which can significantly impact the patient’s quality of life.
Researchers at Dana-Farber/Brigham and Women’s Cancer Center (DF/BWCC) are advancing innovative approaches to decrease tumor recurrence rates in patients with HPV-negative squamous cell carcinoma of the head and neck (SCCHN).
The Division of Otolaryngology-Head and Neck Surgery at Brigham and Women’s Hospital offers expert, individualized care for a range of conditions affecting the ear, nose and throat. Since 2017, Ravindra Uppaluri, MD, PhD, has served as the division chief for the group’s multidisciplinary faculty and staff.
A Phase 2 trial run by the Adult Head and Neck Oncology Program at Dana-Farber/Brigham and Women’s Cancer Center (DF/BWCC) is seeking to reduce the side effects of postoperative therapy for certain head and neck cancer patients, helping them have a better quality of life while maintaining cancer cure rates.
Should allergy medications such as intranasal steroids and oral antihistamines be used to treat isolated otitis media with effusion (OME)? The answer is a resounding no, according to a review of previously collected data published in October’s Current Allergy and Asthma Reports. Rachel E. Roditi, MD, of the Brigham and Women’s Hospital Division of Otolaryngology-Head and Neck Surgery is lead author of the paper.